Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients

Kidney International

Volumn 63, Issue 3, 2003, Pages 793-808

  Kalantar Zadeh, Kamyar ^a   Block, Gladys ^b   Humphreys, Michael H ^b   Kopple, Joel D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Cardiovascular risk factors; Dialysis; ESRD; Malnutrition inflammation complex syndrome; Reverse epidemiology; Risk factor paradox

Indexed keywords

CHOLESTEROL; CREATININE; HOMOCYSTEINE;

BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOCHOLESTEROLEMIA; INFLAMMATION; MALNUTRITION; MORTALITY; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SURVIVAL;

EID: 0037337398     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00803.x     Document Type: Review

References (138)

1. US Renal Data System, USRD 2000 Annual Data Report, in Atlas of End Stage Renal Diseases in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001
2. FOLEY RN, PARFREY PS, SARNAK MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32(Suppl 1):S112-S119, 1998
3. KOPPLE JD: Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J 43:246-250, 1997
4. KOPPLE JD, ZHU X, LEW NL, LOWRIE EG: Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 56:1136-1148, 1999
5. LOWRIE EG, LEW NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482, 1990
6. CORESH J, LONGENECKER JC, MILLER ER, et al: Epidemiology of cardiovascular risk factors in chronic renal disease. J Am Soc Nephrol 9(Suppl 1):S24-S30, 1998
7. KALANTAR-ZADEH K, KOPPLE JD: Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38:1343-1350, 2001
8. FLEISCHMANN EH, BOWER JD, SALAHUDEEN AK: Risk factor paradox in hemodialysis: Better nutrition as a partial explanation. ASAIO J 47:74-81, 2001
9. NISHIZAWA Y, SHOJI T, ISHIMURA E, et al: Paradox of risk factors for cardiovascular mortality in uremia: Is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis 38(Suppl 1):S4-S7, 2001
10. RITZ E, NOWICKI M, WIECEK A: Excess cardiovascular mortality in the uremic patient - What does it teach for other risk factors in the non-renal patient? Pol Arch Med Wewn 92:110-116, 1994
11. STEVENS J, CAI J, PAMUK ER, et al: The effect of age on the association between body-mass index and mortality. N Engl J Med 338:1-7, 1998
12. LANDI F, ONDER G, GAMBASSI G, et al: Body mass index and mortality among hospitalized patients. Arch Intern Med 160:2641-2644, 2000
13. CHANG AK, BARRETT-CONNOR E, EDELSTEIN S: Low plasma cholesterol predicts an increased risk of lung cancer in elderly women. Prev Med 24:557-562, 1995
14. KUCZMARSKI RJ, FLEGAL KM, CAMPBELL SM, JOHNSON CL: Increasing prevalence of overweight among U.S. adults: The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 272:205 211, 1994
15. BYERS T: Body weight and mortality. N Engl J Med 333:723-724, 1995
16. MANSON JE, WILLETT WC, STAMPFER MJ, et al: Body weight and mortality among women. N Engl J Med 333:677-685, 1995
17. LEW EA, GARFINKEL L: Variations in mortality by weight among 750,000 men and women. J Chronic Dis 32:563 565, 1979
18. MACDONALD FC: Quetelet index as indicator of obesity. Lancet 1:1043, 1986
19. KUSHNER RF: Body weight and mortality. Nutr Rev 51:127-136, 1993
20. LEAVEY SF, STRAWDERMAN RL, JONES CA, et al: Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 31:997-1006, 1998
21. FLEISCHMANN E, TEAL N, DUDLEY J, et al: Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 55:1560-1567, 1999
22. WONG JS, PORT FK, HULBERT-SHEARON TE, et al: Survival advantage in Asian American end-stage renal disease patients. Kidney Int 55:2515-2523, 1999
23. DEGOULET P, LEGRAIN M, REACH I, et al: Mortality risk factors in patients treated by chronic hemodialysis: Report of the Diaphane Collaborative Study. Nephron 31:103-110, 1982
24. WOLFE RA, ASHBY VB, DAUGIRDAS JT, et al: Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 35:80-88, 2000
25. PORT FK, ASHBY VB, DHINGRA RK, et al: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13:1061-1066, 2002
26. LEAVEY SF, MCCULLOUGH K, HECKING E, et al: Body mass index and mortality in "healthier" as compared with "sicker" haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 16:2386-2394, 2001
27. YOUNG EW, GOODKIN DA, MAPES DL, et al: The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study. Kidney Int 57(Suppl 1):S74-S81, 2000
28. Canada-USA (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcome. J Am Soc Nephrol 7:198-207, 1996
29. HAKIM RM, LOWRIE E: Obesity and mortality in ESRD: Is it good to be fat? Kidney Int 55:1580-1581, 1999
30. MCCUSKER FX, TEEHAN BP, THORPE KE, et al: How much peritoneal dialysis is required for the maintenance of a good nutritional state? Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Kidney Int 50(Suppl 56):S56-61, 1996
31. JOHNSON DW, HERZIG KA, PURDIE DM, et al: Is obesity a favorable prognostic factor in peritoneal dialysis patients? Perit Dial Int 20:715-721, 2000
32. CHUNG SH, LINDHOLM B, LEE HB: Influence of initial nutritional status on continuous ambulatory peritoneal dialysis patient survival. Perit Dial Int 20:19-26, 2000
33. KAIZU Y, TSUNEGA Y, YONEYAMA T, et al: Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients. Clin Nephrol 50:44-50, 1998
34. GRABOWSKI DC, ELLIS JE: High body mass index does not predict mortality in older people: Analysis of the Longitudinal Study of Aging. J Am Geriatr Soc 49:968-979, 2001
35. VAN DEN HOOGEN PCW, FESKENS EJM, NAGELKERKE NJD, et al: The seven countries study research group. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. N Engl J Med 342:1-8, 2000
36. GASOWSKI J, FAGARD RH, STAESSEN JA, et al: Pulsatile blood pressure component as predictor of mortality in hypertension: A meta-analysis of clinical trial control groups. J Hypertens 20:145-151, 2002
37. VASAN RS, LARSON MG, LEIP EP, et al: Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345:1291-1297, 2001
38. FOLEY RN, PARFREY PS, HARNETT JD, et al: Impact of hypertension of cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385, 1996
39. HEALTH CARE FINANCING ADMINISTRATION: Core Indicators Project initial results: Opportunities to improve care for adult in-center hemodialysis patients. Baltimore, MD, Department of Health and Human Services. Health Care Financing Administration, 1994,
40. INNES A, CHARRA B, BURDEN RP, et al: The effect of long, slow haemodialysis on patient survival. Nephrol Dial Transplant 14:919-922, 1999
41. KATZARSKI KS, CHARRA B, LUIK AJ, et al: Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 14:369-375, 1999
42. CHEIGH JS, MILITE C, SULLIVAN JF, et al: Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 19:453-459, 1992
43. RAHMAN M, DIXIT A, DONLEY V, et al: Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis 33:498-506, 1999
44. DURANTI E, IMPERIALI P, SASDELLI M: Is hypertension a mortality risk factor in dialysis? Kidney Int 49(Suppl 55):S173-S174, 1996
45. SALEM MM: Hypertension in the hemodialysis population? High time for answers. Am J Kidney Dis 33:592-594, 1999
46. SALEM MM: Hypertension in the haemodialysis population: Any relationship to 2-years survival? Nephrol Dial Transplant 14:125-128, 1999
47. ZAGER PG, NIKOLIC J, BROWN RH, et al: "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 54:561-569, 1998
48. LOWRIE EG, HUANG WH, LEW NL, LIU Y: The relative contribution of measured variables to death risk among hemodialysis patients, in Death on Hemodialysis, edited by FRIEDMAN EA, Boston, Kluwer Academic, 1994, pp 121-141
49. ISEKI K, MIYASATO F, TOKUYAMA K, et al: Low diastolic blood pressure, hypoalbuminemia and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 51:1212-1217, 1997
50. CHEUNG AK, SARNAK MJ, YAN G, et al: Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58:353-362, 2000
51. PORT FK, HULBERT-SHEARON TE, WOLFE RA, et al: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 33:507-517, 1999
52. CRUICKSHANK JM, THORPE JM, ZACHARIAS FJ: Benefits and potential harm of lowering high blood pressure. Lancet 1:581-584, 1987
53. BUSBY WJ, CAMPBELL AJ, ROBERTSON MC: Is low blood pressure in elderly people just a consequence of heart disease and frailty? Age Ageing 23:69-74, 1994
54. STENVINKEL P, HEIMBURGER O, PAULTRE F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
55. SHATEN BJ, KULLER LH, NEATON JD: Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group. Prev Med 20:655-659, 1991
56. KLAG MJ, FORD DE, MEAD LA, et al: Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 328:313-318, 1993
57. CUI Y, BLUMENTHAL RS, FLAWS JA, et al: Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161:1413-1419, 2001
58. AVRAM MM, BONOMINI LV, SREEDHARA R, MITTMAN N: Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years. Am J Kidney Dis 28:910-917, 1996
59. ISEKI K, YAMAZATO M, TOZAWA M, TAKISHITA S: Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 61:1887-1893, 2002
60. KALANTAR-ZADEH K, KOPPLE JD, BLOCK G, HUMPHREYS MH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38:1251-1263, 2001
61. GAMBA G, MEJIA JL, SALDIVAR S, et al: Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables. Nephron 65:23-27, 1993
62. CULLEN P, SCHULTE H, ASSMANN G: The Munster Heart Study (PROCAM): Total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers. Circulation 96:2128-2136, 1997
63. VOLPATO S, LEVEILLE SG, CORTI MC, et al: The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc 49:1142-1147, 2001
64. KRUMHOLZ HM, SEEMAN TE, MERRILL SS, et al: Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA 272:1335-1340, 1994
65. MANN JF, GERSTEIN HC, POGUE J, et al: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 134:629-636, 2001
66. RUILOPE LM, SALVETTI A, JAMERSON K, et al: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 12:218-225, 2001
67. CULLETON BF, LARSON MG, WILSON PW, et al: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 56:2214-2219, 1999
68. TATTERSALL J, GREENWOOD R, FARRINGTON K: Urea kinetics and when to commence dialysis. Am J Nephrol 15:283-289, 1995
69. US Renal Data System, USRD 1992 Annual Data Report, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1992
70. FINK JC, BURDICK RA, KURTH SJ, et al: Significance of serum creatinine values in new end-stage renal disease patients. Am J Kidney Dis 34:694-701, 1999
71. GAMBA G, MEJIA JL, SALDIVAR S, et al: Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables. Nephron 65:23-27, 1993
72. NYGARD O, NORDREHAUG JE, REFSUM H, et al: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230-236, 1997
73. MELEADY RA, GRAHAM IM: Homocysteine as a risk factor for coronary artery disease. J. Cardiovasc Risk 2:216-221, 1995
74. ROBINSON K, GUPTA A, DENNIS V, et al: Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 94:2743-2748, 1996
75. MALLAMACI F, ZOCCALI C, TRIPEPI G, et al: Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61:609-614, 2002
76. BACHMANN J, TEPEL M, RAIDT H, et al: Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 6:121-125, 1995
77. JUNGERS P, CHAUVEAU P, BANDIN O, et al: Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. Miner Electrolyte Metab 23:170-173, 1997
78. BOSTOM AG, SHEMIN D, VERHOEF P, et al: Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study. Arteriosc Thromb Vasc Biol 17:2554-2558, 1997
79. MOUSTAPHA A, NASO A, NAHLAWI M, et al: Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97:138-141, 1998
80. BOSTOM AG, SHEMIN D, LAPANE KL, et al: Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Atherosclerosis 123:193-202, 1996
81. SULIMAN ME, QURESHI AR, BARANY P, et al: Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int 57:1727-1735, 2000
82. SULIMAN ME, LINDHOLM B, BARANY P, BERGSTROM J: Hyperhomocysteinemia in chronic renal failure patients: Relation to nutritional status and cardiovascular disease. Clin Chem Lab Med 39:734-738, 2001
83. WRONE EM, ZEHNDER JL, HORNBERGER JM, et al: An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease. Kidney Int 60:1106-1113, 2001
84. HRUSKA KA, TEITELBAUM SL: Renal osteodystrophy. N Engl J Med 333:166-174, 1995
85. LEVIN NW, HOENICH NA: Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr Opin Nephrol Hypertens 10:563-568, 2001
86. AVRAM MM, MITTMAN N, MYINT MM, FEIN P: Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis 38:1351-1357, 2001
87. GUH JY, CHEN HC, CHUANG HY, et al: Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. Am J Kidney Dis 39:1245-1254, 2002
88. GUYATT GH, OXMAN AD, ALI M, et al: Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 7:145-153, 1992
89. KALANTAR-ZADEH K, DON BR, RODRIGUEZ RA, HUMPHREYS MH: Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis 37:564-572, 2001
90. GUNNELL J, YEUN JY, DEPNER TA, KAYSEN GA: Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 33:63-72, 1999
91. HILL JO, MELANSON EL, WYATT HT: Dietary fat intake and regulation of energy balance: implications for obesity. J Nutr 130 (Suppl 2):284S-288S, 2000
92. O'NEIL CE, NICKLAS TA, MYERS L, et al: Cardiovascular risk factors and behavior lifestyles of young women: Implications from findings of the Bogalusa Heart Study. Am J Med Sci 314:385-395, 1997
93. LAIRD NM, BERKEY CS, LOWRIE EG: Modeling success or failure of dialysis therapy: The National Cooperative Dialysis Study. Kidney Int 13(Suppl 1):S101-106, 1983
94. LOWRIE EG, TEEHAN BP: Principles of prescribing dialysis therapy: implementing recommendations from the National Cooperative Dialysis Study. Kidney Int 13(Suppl 1):13-22, 1983
95. KALANTAR-ZADEH K, SUPASYNDH O, LEHN RS, et al: Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V >1.20. J Ren Nutr 13:10-17, 2003
96. JONES CA, MCQUILLAN GM, KUSEK JW, et al: Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 32:992-999, 1998
97. ROTHMAN KJ, GREENLAND S: Sources of bias, in Modern Epidemiology, edited by ROTHMAN KJ, GREENLAND S, Philadelphia, Lipincott-Raven, 1998
98. FRIEDMAN EA: Selection bias impacts outcome reports of uremia therapy. Am J Kidney Dis 36:208-210, 2000
99. Combating undernutrition in the Third World. Lancet 1:334-336, 1988
100. COLLINS S, MYATT M: Short-term prognosis in severe adult and adolescent malnutrition during famine: Use of a simple prognostic model based on counting clinical signs. JAMA 284:621-626, 2000
101. SALAMA P, ASSEFA F, TALLEY L, et al: Malnutrition, measles, mortality, and the humanitarian response during a famine in Ethiopia. JAMA 286:563-571, 2001
102. QURESHI AR, ALVESTRAND A, DIVINO-FILHO JC, et al: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 1(Suppl 1):S28-836, 2002
103. FOLEY RN, PARFREY PS, HARNETT JD, et al: Hypoalbuminemia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 7:728-736, 1996
104. ZIMMERMANN J, HERRLINGER S, PRUY A, et al: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
105. KAYSEN GA, CHERTOW GM, ADHIKARLA R, et al: Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 60:333-340, 2001
106. BERGSTRÖM J, LINDHOLM B: Malnutrition, cardiac disease and mortality: An integrated point of view. Am J Kidney Dis 32:1-10, 1998
107. KAYSEN GA: Malnutrition and the acute-phase reaction in dialysis patients - How to measure and how to distinguish. Nephrol Dial Transplant 15:1521-1524, 2000
108. BERGSTROM J, LINDHOLM B, LACSON E JR, et al: What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients? Semin Dial 13:163-175, 2000
109. KAYSEN GA: The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 12:1549-1557, 2001
110. STENVINKEL P, HEIMBURGER O, LINDHOLM B, et al: Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15:953-960, 2000
111. HIMMELFARB J, MCMONAGLE E: Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int 60:358-363, 2001
112. SPITTLE MA, HOENICH NA, HANDELMAN GJ, et al: Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis 38:1408-1413, 2001
113. LOWRIE EG: Conceptual model for a core pathobiology of uremia with special reference to anemia, malnourishment, and mortality among dialysis patients. Semin Dial 10:115-129, 1997
114. RITZ E: Why are lipids not predictive of cardiovascular death in the dialysis patients? Miner Electrolyte Metab 22:9-12, 1996
115. BOSTOM A, BROSNAN JT, HALL B, et al: Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 116:59-62, 1995
116. GOLDBERG AP, TINDIRA C, HARTER HR: Coronary risk in patients with end stage renal disease: Interaction of hypertension with hyperlipidemia. J Cardiovasc Pharmacol 4 (Suppl 2):S257-S261, 1982
117. PATEL VB, TOPOL EJ: The pathogenesis and spectrum of acute coronary syndromes: From plaque formation to thrombosis. Cleve Clin J Med 66:561-571, 1999
118. WIZEMANN J, KRAMER W: Cardiac arrhythmias in end-stage renal disease: Prevalence, risk factors, and management, in Cardiac Dysfunction in Chronic Uremia, edited by PARFREY PS, HARNETT JD, Boston, Kluwer, 1992, pp 73-79
119. BOLOGA RM, LEVINE DM, PARKER TS, et al: Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107-114, 1998
120. STENVINKEL P, BARANY P, HEIMBURGER O, et al: Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Kidney Int 61:103-108, 2002
121. KAIZU Y, KIMURA M, YONEYAMA T, et al: Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 31:93-100, 1998
122. STENVINKEL P, HEIMBURGER O, JOGESTRAND T: Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 39:274-282, 2002
123. KATO A, ODAMAKI M, TAKITA T, et al: Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. Kidney Int 61:1143-1152, 2002
124. FONG Y, MOLDAWER LL, MARANO M, et al: Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol 256:R659-R665, 1989
125. RIGHETTI M, SESSA A: Cigarette smoking and kidney involvement. J Nephrol 14:3-6, 2001
126. MALATINO LS, BENEDETTO FA, MALLAMACI F, et al: Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. J Nephrol 12:256-260, 1999
127. HASPER D, HUMMEL M, KLEBER FX, et al: Systemic inflammation in patients with heart failure. Eur Heart J 19:761-765, 1998
128. BERMUDEZ EA, RIFAI N, BURING JE, et al: Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 89:1117-1119, 2002
129. CHANG MH, CHOU KJ: The role of autonomic neuropathy in the genesis of intradialytic hypotension. Am J Nephrol 21:357-361, 2001
130. LEV-RAN A: Human obesity: An evolutionary approach to understanding our bulging waistline. Diabetes Metab Res Rev 17:347-362, 2001
131. MONTORI VM, SMIEJA M, GUYATT GH: Publication bias: A brief review for clinicians. Mayo Clin Proc 75:1284-1288, 2000
132. BICKEL C, RUPPRECHT HJ, BLANKENBERG S, et al: Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion. Int J Cardiol 82:25-31, 2002
133. ODA H, KEANE WF: Recent advances in statins and the kidney-Kidney Int 71(Suppl 1):S2-S5, 1999
134. HALKIN A, KEREN G: Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease. Am J Med 112:126-134, 2002
135. CHANG JW, YANG WS, MIN WK, et al: Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients. Am J Kidney Dis 39:1213-1217, 2002
136. KASISKE BL: Cardiovascular disease after renal transplantation. Semin Nephrol 20:176-187, 2000
137. CALLE EE, THUS MJ, PETRELLI JM, et al: Body mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097-1105, 1999
138. LOWRIE EG, LI Z, OFSTHUN N, LAZARUS JM: Body size, dialysis dose and death risk relationships among hemodialysis patients. Kidney Int 62:1891-1897, 2002